US WorldMeds, a Kentucky-based specialty pharmaceutical company, announced Walgreens will stock LUCEMYRA (lofexidine) tablets in Walgreens pharmacies across the U.S., effective September 1.
|
LOUISVILLE, Ky., Aug. 31, 2021 /PRNewswire/ -- US WorldMeds, a Kentucky-based specialty pharmaceutical company, announced Walgreens will stock LUCEMYRA (lofexidine) tablets in Walgreens pharmacies across the U.S., effective September 1. LUCEMYRA is the only FDA-approved, non-opioid, non-addictive treatment for relief of multiple symptoms of opioid withdrawal in adults and requires a valid prescription to be dispensed.1 Eligible patients covered by commercial insurance will pay $0* for a LUCEMYRA prescription. Patients without insurance coverage for LUCEMYRA may be eligible to pay $300 for a LUCEMYRA prescription.
According to provisional data released in July by the National Center for Health Statistics, more than 93,000 people died from drug overdoses in 2020, a death toll jump of more than 21,000, or nearly 30%, far eclipsing the record set the prior year.2 More than 900,000 people have died of overdoses since the U.S. drug epidemic began in 1999, according to the Centers for Disease Control and Prevention.3 Overdose deaths involving opioids have continued to drive the death toll, accounting for 69,710 overdose deaths in 2020, up from 50,963 in 2019.2 "LUCEMYRA offers hope for people who want to discontinue opioid use and struggle with the agonizing symptoms of opioid withdrawal," said P. Breckinridge Jones, Chief Executive Officer and founder of US WorldMeds. "US WorldMeds is committed to helping patients in need. We are extremely proud to be partnering with Walgreens, a premier national pharmacy retailer, in support of this vitally important issue." * Patients whose prescriptions will be paid for in part or in whole by Medicare, Medicaid, or any similar federal or state healthcare program, are not eligible for savings or rebates according to federal and state law. Patients must visit a participating pharmacy for savings or rebates on their LUCEMYRA prescriptions. Maximum benefits may apply. The actual savings on out-of-pocket costs for LUCEMYRA will vary according to refill quantity, personal healthcare insurance coverage, and adherence to FDA dosing guidelines. For more information about the LUCEMYRA Prescription Savings Co-Pay Assistance Program, please review the Terms and Conditions on LUCEMYRA.com. LUCEMYRA® (lofexidine) – Important Safety Information LUCEMYRA is a non-opioid prescription medicine used in adults to help with the symptoms of opioid withdrawal that may happen when you stop taking an opioid suddenly. LUCEMYRA will not completely prevent the symptoms of opioid withdrawal and is not a treatment for opioid use disorder. Important Safety Information: When your treatment is complete, you will need to stop taking LUCEMYRA gradually, or your blood pressure could increase. After a period of not using opioid drugs, you can become more sensitive to the effects of opioids if you start using them again. This may increase your risk of overdose and death. Before taking LUCEMYRA, tell your healthcare provider about all your medical conditions, including if you have low blood pressure, slow heart rate, any heart problems including history of heart attack or a condition called long QT syndrome, liver or kidney problems, or if you drink alcohol. Tell your healthcare provider if you are pregnant, plan on becoming pregnant, or are breastfeeding; it is not known if LUCEMYRA can harm your unborn baby or whether LUCEMYRA passes into your breast milk. Especially tell your healthcare provider if you take benzodiazepines, barbiturates, tranquilizers, or sleeping pills, as taking these with LUCEMYRA can cause serious side effects. The most common side effects of LUCEMYRA include low blood pressure or symptoms of low blood pressure such as lightheadedness, slow heart rate, dizziness, sleepiness, and dry mouth. To report SUSPECTED ADVERSE REACTIONS or product complaints, contact US WorldMeds at 1-833-LUCEMYRA. You may also report SUSPECTED ADVERSE REACTIONS to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. Please click here to access the full U.S. Prescribing Information and Patient Information for LUCEMYRA. About Opioid Withdrawal About US WorldMeds About Walgreens References USWMLUC-00429 Media inquiries:
SOURCE US WorldMeds, LLC |
||
Company Codes: NASDAQ-NMS:WBA |
View original content to download multimedia: